CD4 and rheumatoid arthritis: We next investigated the expression of TRAIL and its receptors on CD8+ T cells of RA patients and compared with healthy controls, similar to CD4+ T cells, we found significant differences between the two groups as shown in Figure 3A (p < 0.05).